Production (Stage)
Fate Therapeutics, Inc.
FATE
$1.28
-$0.125-8.93%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -13.85% | -6.01% | -2.61% | -20.51% | 21.69% |
| Total Receivables | -21.87% | -6.44% | 119.32% | 56.31% | -35.51% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -52.99% | -1.93% | -37.56% | 29.63% | -33.48% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -14.97% | -5.93% | -2.85% | -19.01% | 18.95% |
|
|
|||||
| Total Current Assets | -14.97% | -5.93% | -2.85% | -19.01% | 18.95% |
| Net Property, Plant & Equipment | -2.66% | -21.26% | -4.25% | -3.70% | -3.64% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.09% | 0.00% | -32.60% | 0.00% | 0.00% |
| Total Assets | -9.54% | -10.97% | -6.40% | -7.21% | 12.58% |
|
|
|||||
| Total Accounts Payable | -55.26% | 47.50% | 15.54% | -18.77% | 43.36% |
| Total Accrued Expenses | -19.37% | -9.47% | 4.09% | -29.30% | 16.46% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -11.76% | 7.59% | 3.75% | 3.78% | 3.66% |
| Total Finance Division Other Current Liabilities | -46.06% | -34.50% | -- | -- | -76.79% |
| Total Other Current Liabilities | -46.06% | -34.50% | -- | -- | -76.79% |
| Total Current Liabilities | -26.90% | 2.94% | 7.56% | -23.31% | 16.05% |
|
|
|||||
| Total Current Liabilities | -26.90% | 2.94% | 7.56% | -23.31% | 16.05% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -1.37% | -15.46% | -1.95% | -1.83% | -1.74% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -5.00% | 78.42% | 0.42% | 14.01% | 103.57% |
| Total Liabilities | -9.60% | -8.05% | 0.61% | -8.31% | 4.34% |
|
|
|||||
| Common Stock & APIC | 0.43% | 0.53% | 0.69% | 0.56% | 6.70% |
| Retained Earnings | -2.69% | -3.88% | -3.67% | -3.05% | -3.96% |
| Treasury Stock & Other | -28.73% | -67.90% | 297.87% | -117.53% | -1,393.33% |
| Total Common Equity | -9.51% | -12.03% | -8.73% | -6.84% | 15.66% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | -9.51% | -12.03% | -8.73% | -6.84% | 15.66% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -9.51% | -12.03% | -8.73% | -6.84% | 15.66% |
|
|
|||||